Skip to content
Screener

CONMED CNMD Europe, Middle East & Africa — Net Sales

Other geography segments

Asia Pacific
$57.16M+9.7%
Americas (excluding the United States)
$34.8M+9.2%

Similar metrics at other companies

Timken logo
TKREurope / Middle East / Africa — Net Sales
$309.4M+14.9%
Vertiv Holdings Co logo
VRTEurope, Middle East, & Africa — Net Sales
$710.5M+15.5%
SOL
SOLSEurope, Middle East and Africa — Net Sales
$230.5M+4.1%
NewMarket logo
NEUEurope, Middle East, Africa, India — Net Sales
$224.68M+5.5%
International Flavors & Fragrances logo
IFFEurope, Africa and Middle East — Net Sales
$949M-0.3%
Tennant Company logo
TNCEurope, Middle East and Africa — Net Sales
$86.5M+2.1%

Other financials

Income statement

See full
Revenue$343.5M+0.3%
Gross profit$197.5M+4.9%
Operating income$36.4M-4.6%
Net income$23.1M+7.7%
EPS (diluted)$0.77+11.6%

Balance sheet

See full
Cash & equivalents$37.3M+10.0%
Total debt$1.0B+14.5%
Total equity$1.0B+3.8%
Total assets$2.3B-1.2%

Cash flow

See full
Operating cash flow$37.1M+27.3%
CapEx$2.9M-48.8%
Free cash flow$34.2M+46.0%

Valuation

See full
Market cap$1.47B-9.4%
Enterprise value$2.45B-1.1%
P/E26×+11.3×
P/S1.1×-0.2×

Profitability

See full
Gross margin55.8%-0.3pp
Operating margin8%-5.0pp
Net margin4.1%-4.2pp
FCF margin9.8%-1.4pp

Returns & leverage

See full
Return on equity5.5%-6.2pp
Debt / equity+0.1×
Current ratio1.5×-0.7×

Where this comes from

Reported directly by CONMED in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: CONMED’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:13 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000816956-26-000102
Line itemThree Months Ended / June 30, 2026 / Orthopedic SurgeryThree Months Ended / June 30, 2026 / General SurgeryThree Months Ended / June 30, 2026 / TotalThree Months Ended / June 30, 2025 / Orthopedic SurgeryThree Months Ended / June 30, 2025 / General SurgeryThree Months Ended / June 30, 2025 / Total
Primary Geographic Markets
United States$51,653$123,732$175,385$51,687$138,925$190,612
Europe, Middle East & Africa40,30535,84276,14735,58832,18967,777
Asia Pacific36,56120,59657,15731,73620,34552,081
Americas (excluding the United States)23,79611,00334,79921,72310,15231,875
Total sales from contracts with customers$152,315$191,173$343,488$140,734$201,611$342,345
Timing of Revenue Recognition
Goods transferred at a point in time$139,852$188,205$328,057$129,382$199,065$328,447

Item 1. Financial Statements (unaudited)

FAQ

What is CONMED's europe, middle east & africa — net sales?
CONMED (CNMD) reported europe, middle east & africa — net sales of $76.15M in Q2 2026.
How has CONMED's europe, middle east & africa — net sales changed year-over-year?
CONMED's europe, middle east & africa — net sales increased by 12.3% year-over-year, from $67.78M to $76.15M.
What is the long-term trend for CONMED's europe, middle east & africa — net sales?
Over 4 years (2021 to 2025), CONMED's europe, middle east & africa — net sales has grown at a 8.7% compound annual growth rate (CAGR), from $189.69M to $264.65M.
What does europe, middle east & africa — net sales mean?
This metric represents the total revenue generated from the sale of medical devices and equipment within the Europe, Middle East, and Africa geographic region. It serves as a key indicator of the company's international market penetration and demand for its surgical product portfolio outside of its primary domestic market. Tracking this figure allows investors to assess the company's geographic diversification and the success of its commercial strategy in these specific international territories.

Ask your AI about CONMED's europe, middle east & africa — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude